The RAS/RAF/MEK/ERK (MAPK/ERK) pathway is hyperactivated and takes an active part in the malignant transformation in most cancers [52,53,54], including melanoma [55], and neuroblastoma [56] (cancers that have neural tube cells as the embryological origin). This evidence concerns the gene MAP2K7 and melanoma.